(Q34986723)

5 August 2017

1 reference

title

Marijuana withdrawal syndrome in the animal model (English)

1 reference

5 August 2017

Aron H Lichtman

1

1 reference

PubMed ID

12412832

5 August 2017

Billy R Martin

series ordinal

2

1 reference

5 August 2017

1 November 2002

1 reference

The Journal of Clinical Pharmacology

5 August 2017

1 reference

5 August 2017

42

1 reference

5 August 2017

20S-27S

1 reference

5 August 2017

11 Suppl

1 reference

Aspects of tolerance to and dependence on cannabis

5 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Abstinence symptoms following oral THC administration to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Abstinence symptoms following smoked marijuana in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Marijuana abstinence effects in marijuana smokers maintained in their home environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

A review of the published literature into cannabis withdrawal symptoms in human users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Effects of SR 141716A after acute or chronic cannabinoid administration in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Precipitated and spontaneous withdrawal in rats tolerant to anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Clonidine blocks acute opiate-withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Clonidine and the treatment of the opiate withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05999.X

10.1002/J.1552-4604.2002.TB05999.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12412832